# A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward

> **NCT00605241** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 29 (actual)

## Conditions studied

- Substance Dependence

## Interventions

- **DRUG:** GSK598809

## Key facts

- **NCT ID:** NCT00605241
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-25
- **Primary completion:** 2009-03-20
- **Final completion:** 2009-03-20
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605241, "A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00605241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*